Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Windlas Biotech has informed that it attached Q3 FY23 Earnings Conference Call Transcript.
The above information is a part of company’s filings submitted to BSE.